CHA Bio Group head outlines vision for stem cells to fight diseases, extend life
Dr. Cha Kwang-yul, head of the CHA Global Research Institutes at CHA Medical Center and CHA Bio Group, outlined an ambitious vision to use stem cells to treat intractable diseases and potentially extend human lifespan, drawing global interest at an international conference in Busan. Cha delivered his keynote address, titled "Longevity and Reproductive Aging Using K-Cells," at the 16th World…
Dr. Cha Kwang-yul, who leads the CHA Global Research Institutes within CHA Medical Center and CHA Bio Group, shared an ambitious vision at an international conference in Busan. His presentation, titled "Longevity and Reproductive Aging Using K-Cells," was delivered during the 16th World Congress of the International Society for Immunology of Reproduction. The event attracted approximately 400 attendees.
The focus of Dr. Cha's address was K-Cell, a proposed cell resource aimed at developing treatments for challenging diseases before exploring research into aging and longevity. He introduced a comprehensive donor-screening strategy that takes into account medical and infectious disease histories, age, clinical characteristics, the medical history of three generations of a family, and whole-genome sequencing to identify cells suitable for particular therapeutic uses.
In addition to discussing the K-Cell approach, Dr. Cha also addressed genetic modification and somatic cell nuclear transfer, a technique involving the transfer of a cell's nucleus to initiate the development of new cells.
Written by urgent.news from The Korea Times's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
